Some strains are commercially available as a probiotic that can be used by premenopausal and postmenopausal women that experience recurrent urinary tract infections.[3][4] For example, one strain CTV-05 is being evaluated specifically for the prevention and treatment of bacterial vaginosis,[5] which is characterized by overgrowth of other bacteria, potentially as a result of the absence of Lactobacillus flora that can serve to protect the host from infection.[6]
^Ravel, J; Gajer, P; Abdo, Z; Schneider, GM; Koenig, SS; McCulle, SL; Karlebach, S; Gorle, R; Russell, J; Tacket, CO; Brotman, RM; Davis, CC; Ault, K; Peralta, L; Forney, LJ (15 March 2011). "Vaginal microbiome of reproductive-age women". Proceedings of the National Academy of Sciences of the United States of America. 108 Suppl 1 (Suppl 1): 4680–7. doi:10.1073/pnas.1002611107. PMC3063603. PMID20534435.